skip to content
Pharmacocinétique et biotransformations du Lamisil R (terbinafine) et de ses 3 principaux métabolites après administration orale à doses croissantes et répétées chez le sujet sain Preview this item
ClosePreview this item
Checking...

Pharmacocinétique et biotransformations du Lamisil R (terbinafine) et de ses 3 principaux métabolites après administration orale à doses croissantes et répétées chez le sujet sain

Author: Véronique Agathon; Jean-Michel Scherrmann
Publisher: [S.l.] : [s.n.], 1996.
Dissertation: Thèse de doctorat : Pharmacie : Paris 5 : 1996. 147.
Edition/Format:   Thesis/dissertation : Thesis/dissertation : French
Database:WorldCat
Rating:

(not yet rated) 0 with reviews - Be the first.

Subjects
More like this

 

Find a copy in the library

&AllPage.SpinnerRetrieving; Finding libraries that hold this item...

Details

Material Type: Thesis/dissertation
Document Type: Book
All Authors / Contributors: Véronique Agathon; Jean-Michel Scherrmann
OCLC Number: 489950132
Notes: 1996PA05P147.
Description: 48, lxviii f. ; 30 cm.
Responsibility: Véronique Agathon.

Reviews

User-contributed reviews
Retrieving GoodReads reviews...
Retrieving DOGObooks reviews...

Tags

Be the first.
Confirm this request

You may have already requested this item. Please select Ok if you would like to proceed with this request anyway.

Linked Data


<http://www.worldcat.org/oclc/489950132>
library:oclcnum"489950132"
library:placeOfPublication
library:placeOfPublication
owl:sameAs<info:oclcnum/489950132>
rdf:typej.2:Thesis
rdf:typeschema:Book
schema:about
schema:contributor
schema:creator
schema:datePublished"1996"
schema:exampleOfWork<http://worldcat.org/entity/work/id/365387996>
schema:name"Pharmacocinétique et biotransformations du Lamisil R (terbinafine) et de ses 3 principaux métabolites après administration orale à doses croissantes et répétées chez le sujet sain"
schema:publisher
schema:url

Content-negotiable representations

Close Window

Please sign in to WorldCat 

Don't have an account? You can easily create a free account.